Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Series B financing brings $3.5mm to Orasi Medical

Executive Summary

University of Minnesota spin-off Orasi Medical brought in $3.5mm through its Series B round from 31 investors. (According to the Form D, the start-up had planned to raise up to $8.8mm.) Among the participants were Series A shareholders PrairieGold Venture Partners and CentreStone Ventures (leads), angel investors, and company management. Orasi will use the money to develop and expand the use of its Synchronous Neural Interactions test in pharmaceutical and clinical diagnostic applications. SNI quickly and accurately provides early diagnosis of CNS diseases (the company is initially targeting Alzheimer's) and assesses efficacy of drugs by measuring small magnetic signals generated by electrical brain activity.
Deal Industry
  • In Vitro Diagnostics
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register